Published on

Infectious Disease and Microbiology – Comamonas Species

Overview

Comamonas species are aerobic Gram-negative bacilli of generally low pathogenicity. They are common environmental organisms and only rarely cause human disease. Because they can also appear as incidental laboratory contaminants, a positive culture should always be interpreted in the context of the patient’s clinical presentation.

The clinically recognized species include Comamonas acidovorans, Comamonas terrigena, and Comamonas testosteroni, with C. testosteroni being the species most often associated with human infection.

Microbiologic Characteristics

Comamonas organisms are aerobic Gram-negative rods. They are primarily environmental bacteria and are not considered major components of normal human flora.

Their low intrinsic virulence means that infection usually occurs in patients with important predisposing factors, such as immunosuppression, intravenous drug use, or disruption of normal tissue barriers.

Epidemiology

These bacteria are widely distributed in the environment, including soil and water. Human infection is uncommon.

Because Comamonas may occasionally contaminate clinical specimens, the significance of an isolated positive culture depends on factors such as repeated recovery from sterile sites, compatible symptoms, and the absence of a more plausible pathogen.

Endocarditis

Comamonas species have rarely been associated with infective endocarditis, particularly in people who inject drugs.

Clinical features may include:

• Persistent fever

• Cardiac murmur

• Embolic phenomena

• Positive blood cultures

Repeated isolation from blood in a compatible clinical setting supports true infection rather than contamination.

Bacteremia

Bacteremia may occur, especially in immunocompromised patients.

Possible manifestations include:

• Fever

• Chills

• Hypotension

• Sepsis in severe cases

As with other unusual Gram-negative organisms, identification from multiple blood cultures makes a true bloodstream infection more likely.

Keratitis

C. acidovorans has rarely been reported as a cause of keratitis and corneal ulceration.

Patients may present with:

• Eye pain

• Redness

• Photophobia

• Corneal opacity or ulceration

• Reduced vision

Prompt ophthalmologic assessment is important because progressive corneal infection can threaten vision.

Diagnosis

Diagnosis is established by culture of the organism from an appropriate specimen.

Depending on the syndrome, specimens may include:

• Blood

• Cardiac-related samples

• Corneal scrapings

• Other infected tissue or fluid

Because contamination is possible, clinicians should correlate the microbiologic result with the overall clinical picture.

Interpreting a Positive Culture

A positive culture is more likely to represent true infection when:

• The organism is recovered repeatedly

• It is isolated from a normally sterile site

• The patient has compatible symptoms

• There are recognized risk factors

• No more likely pathogen is identified

A single positive culture without clinical evidence of infection may represent contamination.

Treatment

There are limited clinical data defining the optimal antimicrobial regimen for Comamonas infections.

Available experience suggests that antipseudomonal agents may be active against many isolates.

Potential choices may include selected:

• Antipseudomonal beta-lactams

• Fluoroquinolones

• Other active Gram-negative agents

Definitive therapy should be guided by antimicrobial susceptibility testing whenever possible.

Severe Infection

For endocarditis, bacteremia, or another invasive infection, management should include:

• Susceptibility-directed antimicrobial therapy

• Assessment for an infected catheter or other source

• Echocardiography if endocarditis is suspected

• Source control when necessary

High-Yield Clinical Pattern

Unusual Gram-negative bacillus in blood culture

  • ●

Intravenous drug use or immunosuppression

  • ●

Compatible bacteremia or endocarditis

→ Consider true Comamonas infection, while still evaluating carefully for contamination.

Exam Essentials

Genus: Comamonas

Important species: C. testosteroni, C. acidovorans, C. terrigena

Most common human species: C. testosteroni

Microbiology: Aerobic Gram-negative bacillus

Virulence: Generally low

Typical habitat: Environment

Major infections: Endocarditis, bacteremia, rare keratitis

Important risk groups: Intravenous drug users and immunocompromised patients

Diagnosis: Culture

Important interpretation issue: May represent contamination

Treatment: Limited evidence; antipseudomonal agents may be effective, ideally guided by susceptibility testing

Key clinical pearl: Comamonas is usually a low-virulence environmental organism, so the major challenge is deciding whether a positive culture represents true invasive infection or contamination.


Image description
Published on

Infectious Disease and Microbiology – Colorado Tick Fever Virus

Overview

Colorado tick fever (CTF) is an acute tick-borne viral infection caused by Colorado tick fever virus, a member of the genus Coltivirus. The illness is typically characterized by an acute febrile syndrome following exposure to infected ticks in endemic mountainous regions. Most infections are self-limited, although neurologic complications such as meningitis and encephalitis can occur, particularly in children.

Microbiology

Colorado tick fever virus is a nonenveloped, double-stranded RNA virus belonging to the coltivirus group. Unlike many other medically important arboviruses, which contain single-stranded RNA, coltiviruses possess a segmented double-stranded RNA genome.

Other tick-associated arboviral illnesses have historically been associated with viruses such as Kemerovo, Nairobi sheep disease/Ganjam, Lipovnik, Quaranfil, Bhanja, Thogoto, and Dugbe viruses, although these represent distinct viral groups and epidemiologic settings.

Incubation Period

Symptoms of Colorado tick fever usually develop approximately 5 days after the bite of an infected tick.

Epidemiology and Transmission

Colorado tick fever occurs primarily in the mountainous regions of the western United States and western Canada, particularly at elevations above approximately 5,000 feet (1,500 meters).

Humans acquire infection through the bite of an infected tick. Consequently, people who spend substantial time outdoors in endemic mountainous areas are at greatest risk. This includes hikers, campers, hunters, forestry workers, and people involved in other recreational or occupational activities that increase exposure to ticks.

Clinical Manifestations

Colorado tick fever usually presents as an acute febrile illness. Patients may develop fever and constitutional symptoms following the incubation period.

A characteristic feature described with this infection is a biphasic (“saddleback”) fever, in which the initial fever improves and then returns after a short afebrile interval.

Although most cases remain uncomplicated, infection can occasionally involve the central nervous system. Meningitis and encephalitis are important complications and occur disproportionately in children.

Diagnosis

Diagnosis can be established using serologic testing to demonstrate an immune response to Colorado tick fever virus.

The virus can also be identified by specialized laboratory techniques, including viral culture, although culture is not routinely required in typical clinical practice. Molecular assays may also be available through specialized or public-health laboratories.

Treatment

There is no specific antiviral therapy for Colorado tick fever.

Management is therefore supportive and symptomatic, with measures such as adequate hydration, rest, treatment of fever and pain, and monitoring for neurologic or other complications. Patients with significant CNS involvement may require hospitalization and more intensive supportive management.

Prevention

Prevention centers on avoiding tick bites, especially when visiting endemic mountainous regions. Protective measures include wearing clothing that reduces exposed skin, using appropriate tick repellents, avoiding heavily tick-infested vegetation when possible, and performing careful tick checks after outdoor activities.

Prompt removal of attached ticks is an important general tick-bite prevention measure.

High-Yield Clinical Pearls

Vector: Tick

Geography: Mountainous western United States and Canada, particularly >5,000 ft

Virus: Coltivirus

Genome: Double-stranded RNA

Envelope: Nonenveloped

Incubation: Approximately 5 days

Typical disease: Acute febrile illness, classically with biphasic fever

Important complication: Meningitis or encephalitis, especially in children

Diagnosis: Primarily serologic/molecular testing

Treatment: Supportive; no specific antiviral therapy

Prevention: Tick-bite avoidance



Image description
Published on

Infectious Disease and Microbiology – Clostridium Species

Overview

Clostridium species are anaerobic, Gram-positive bacilli capable of causing illnesses ranging from self-limited food poisoning to rapidly progressive, life-threatening soft-tissue infection and bacteremia. Important species include C. perfringens, C. septicum, C. sordellii, C. novyi, C. histolyticum, C. bifermentans, C. butyricum, C. clostridioforme, and C. ramosum. Other clinically important clostridia, including C. difficile, C. botulinum, and C. tetani, are generally considered separately.

Microbiology

Clostridia are Gram-positive, anaerobic bacilli. Many clinically important members of the genus are spore-forming organisms capable of surviving unfavorable environmental conditions. Their pathogenicity varies considerably by species and may involve tissue invasion, toxin production, or both. Several species produce potent exotoxins and tissue-degrading enzymes that account for the rapid tissue destruction seen in severe clostridial infections.

Epidemiology and Incubation

Clostridial infections occur worldwide. Exposure may arise from environmental contamination, ingestion of contaminated food, or invasion by organisms that are part of the gastrointestinal or genital microbial flora. In clostridial food poisoning, symptoms generally develop 6–24 hours after ingestion, most commonly within approximately 8–12 hours.

Clinical Infections

Clostridia cause a broad spectrum of disease. Food poisoning is generally characterized by an acute, self-limited gastrointestinal illness. Invasive disease may produce bacteremia, particularly in patients with significant underlying illness.

Localized clostridial infections are often polymicrobial and can involve the biliary tract, intra-abdominal spaces, surgical sites, wounds, and other soft tissues. Some species can cause rapidly destructive infections characterized by tissue necrosis and gas formation.

Gas Gangrene

Clostridial myonecrosis, commonly called gas gangrene, is one of the most severe manifestations. C. perfringens is a classic cause, although other clostridia can produce similar disease. Infection progresses rapidly through muscle and surrounding tissues, producing severe pain, edema, tissue necrosis, systemic toxicity, and potentially shock.

The rapid progression reflects bacterial proliferation under anaerobic conditions combined with the production of powerful exotoxins and tissue-destructive enzymes.

Clostridium septicum

C. septicum deserves particular attention because spontaneous bacteremia or gas gangrene may indicate an underlying colonic malignancy or other structural gastrointestinal lesion.

Therefore, isolation of C. septicum from blood—particularly without an obvious traumatic source—should prompt investigation for:

Colorectal malignancy or another significant gastrointestinal lesion.

This is a particularly important clinical and examination association.

Clostridium sordellii

C. sordellii can cause an exceptionally severe toxic syndrome, including postpartum or gynecologic infection associated with profound hypotension and shock. Severe disease may progress rapidly and requires urgent recognition and management.

Gastrointestinal Disease

Certain clostridia can cause necrotizing enteritis, characterized by severe intestinal inflammation and necrosis. Clostridial species may also contribute to typhlitis, particularly in neutropenic or severely immunocompromised patients.

By contrast, uncomplicated toxin-mediated clostridial food poisoning is usually self-limited and does not require antimicrobial therapy.

Diagnosis

Diagnosis of invasive clostridial infection primarily depends on anaerobic culture of blood, tissue, aspirated material, or other appropriate clinical specimens.

Because some organisms grow slowly, prolonged culture incubation may occasionally be necessary. In suspected necrotizing soft-tissue infection, diagnostic evaluation must not delay surgical management when the clinical presentation indicates an emergency.

Treatment

Food Poisoning

Uncomplicated clostridial food poisoning generally requires only supportive care, including fluid and electrolyte replacement when necessary.

Antibiotics are usually unnecessary.

Severe Invasive Infection

Historically, penicillin G has been a major treatment for susceptible invasive clostridial infections.

For severe toxin-mediated infections such as clostridial myonecrosis, penicillin plus clindamycin has commonly been used. Clindamycin is particularly useful because inhibition of bacterial protein synthesis may reduce toxin production.

Other agents with anaerobic activity include:

• Metronidazole

• Carbapenems such as meropenem or imipenem

• Clindamycin

• Selected tetracyclines

Antibiotic selection should ultimately take into account the species, infection site, severity, susceptibility results, and whether the infection is polymicrobial.

Surgical Management

Severe clostridial soft-tissue infection is a surgical emergency. Antibiotics alone are inadequate when extensive necrotic tissue is present.

Management generally requires urgent and aggressive surgical exploration and debridement of devitalized tissue, together with antimicrobial therapy and intensive supportive care. Repeated debridement may be necessary when infection continues to progress.

High-Yield Species Associations

Species

Important Association

C. perfringens

Food poisoning, gas gangrene/clostridial myonecrosis

C. septicum

Spontaneous bacteremia or myonecrosis associated with colonic malignancy

C. sordellii

Postpartum/gynecologic infection with profound hypotension and shock

C. novyi

Severe soft-tissue infection and myonecrosis

C. histolyticum

Tissue-destructive infection

Other clostridia

Bacteremia and polymicrobial intra-abdominal, biliary, or soft-tissue infections

Clinical Pearls

The most important pattern to remember is:

Anaerobic Gram-positive bacillus + rapidly progressive painful necrotic wound + gas in tissues → consider clostridial myonecrosis.

Another classic association is:

Spontaneous Clostridium septicum bacteremia or gas gangrene → investigate for colorectal malignancy.

Finally, clostridial food poisoning is generally toxin-mediated and self-limited, whereas invasive clostridial disease can progress extremely rapidly and requires prompt antimicrobial therapy, source control, and—in necrotizing infection—urgent surgery.


Image description
Published on

Infectious Disease and Microbiology – Clonorchis sinensis (Opisthorchis sinensis)

Overview

Clonorchis sinensis, commonly called the Chinese liver fluke, is a foodborne trematode helminth that infects the biliary tract. Human infection, known as clonorchiasis, is acquired by eating raw or inadequately cooked freshwater fish containing infective larvae.

Many infections remain asymptomatic for years. Chronic or heavy infection can cause recurrent biliary inflammation, obstruction, cholangitis, and other hepatobiliary complications. Most importantly, chronic C. sinensis infection is an established risk factor for cholangiocarcinoma.

Microbiologic Characteristics

Clonorchis sinensis is a:

• Trematode

• Flatworm

• Foodborne liver fluke

Adult worms primarily inhabit the intrahepatic bile ducts, where they may survive for many years.

Humans acquire infection by ingesting metacercariae encysted within freshwater fish.

Epidemiology

Clonorchiasis is concentrated in East and Southeast Asia.

Important endemic regions include:

• China, particularly southeastern areas

• Korea

• Taiwan

• Vietnam and other parts of Indochina

• Japan historically and in limited settings

Cases outside endemic areas are usually associated with immigration, travel, or consumption of imported raw freshwater fish.

Transmission

The classic route of transmission is:

Raw/undercooked freshwater fish → ingestion of metacercariae → biliary infection

After ingestion, metacercariae excyst in the duodenum and migrate through the ampulla of Vater into the biliary system.

They subsequently mature into adult flukes within the bile ducts.

Life Cycle

A simplified life cycle is:

Eggs in human feces → freshwater snail → cercariae → freshwater fish → metacercariae → human ingestion → adult worms in bile ducts

Humans acquire infection by eating the infected fish rather than through direct person-to-person transmission.

Clinical Manifestations

The clinical severity depends largely on the number of parasites and duration of infection.

Light infections are frequently asymptomatic.

More substantial or chronic infections may produce:

• Right upper quadrant abdominal discomfort

• Dyspepsia

• Nausea

• Hepatomegaly

• Biliary obstruction

• Jaundice

• Recurrent cholangitis

Symptoms may not become apparent until many years after the initial infection.

Obstructive Jaundice

Large numbers of adult worms, together with chronic inflammation and biliary epithelial changes, can interfere with bile flow.

Patients may develop:

• Jaundice

• Dark urine

• Pale stools

• Pruritus

• Elevated cholestatic liver enzymes

Cholangitis

Chronic biliary infection predisposes to recurrent inflammation and secondary bacterial infection of the biliary tree.

Typical manifestations include:

Fever + right upper quadrant pain + jaundice

This represents the classic Charcot triad of acute cholangitis.

Chronic Biliary Disease

Longstanding clonorchiasis can produce:

• Chronic cholangitis

• Bile duct inflammation and fibrosis

• Biliary obstruction

• Pigment stone formation

• Recurrent pyogenic cholangitis

• Pancreatic involvement in some patients

Repeated epithelial injury is particularly important because of its association with malignant transformation.

Cholangiocarcinoma

The most important long-term complication is cholangiocarcinoma, particularly intrahepatic bile duct cancer.

Chronic infection produces prolonged:

Inflammation → epithelial injury → hyperplasia and dysplasia → increased risk of cholangiocarcinoma

Therefore:

Clonorchis sinensis is a major infectious risk factor for cholangiocarcinoma.

This is one of the highest-yield associations for the organism.

Diagnosis

Stool Examination

The principal parasitologic diagnosis is demonstration of characteristic eggs in the stool.

Because parasite burden may be low, examination of concentrated stool specimens improves diagnostic yield.

Multiple stool specimens may be necessary.

Bile Examination

Eggs can also be identified in bile obtained by:

Duodenal aspiration

This approach may be useful when stool examinations are unrevealing despite strong clinical suspicion.

Serology

Serologic assays may provide supportive evidence of infection.

However, availability is limited, particularly outside endemic regions, and serology does not necessarily distinguish active from previous infection as reliably as direct parasite detection.

Imaging

Although not required to identify the parasite directly, hepatobiliary imaging can help evaluate complications.

Ultrasonography, CT, or MRCP may demonstrate:

• Bile duct abnormalities

• Intrahepatic duct dilation

• Biliary obstruction

• Stones

• Cholangitis-related changes

• A mass suspicious for cholangiocarcinoma

Differential Diagnosis

The differential diagnosis of hepatobiliary fluke infection includes:

• Opisthorchis viverrini

• Opisthorchis felineus

• Fasciola hepatica

• Choledocholithiasis

• Recurrent pyogenic cholangitis

• Primary sclerosing cholangitis

• Biliary malignancy

Importantly, both Clonorchis sinensis and Opisthorchis viverrini are strongly associated with cholangiocarcinoma.

Treatment

Praziquantel

The treatment of choice is generally:

Praziquantel

A commonly used regimen is:

25 mg/kg orally three times daily for 2 days

Praziquantel is highly effective against adult liver flukes.

Albendazole

Albendazole can be used as an alternative.

A regimen historically described is:

Albendazole 10 mg/kg/day orally for 7 days

Praziquantel generally remains the preferred treatment when available.

Management of Complications

Patients with significant biliary obstruction or cholangitis may require additional interventions, such as:

• Antibiotic treatment for bacterial cholangitis

• Endoscopic biliary drainage

• Removal of obstructing material or stones

• Surgical management when indicated

Suspicion for cholangiocarcinoma requires dedicated hepatobiliary evaluation.

Prevention

Prevention depends primarily on avoiding viable metacercariae in freshwater fish.

Effective measures include:

• Thoroughly cooking freshwater fish

• Appropriate freezing or processing where validated

• Avoiding raw or inadequately cooked freshwater fish in endemic areas

• Food-safety education

• Sanitation measures that interrupt contamination of freshwater environments

Irradiation can also destroy infective parasites in fish.

High-Yield Clinical Pattern

Patient from East or Southeast Asia

  • ●

History of eating raw freshwater fish

  • ●

Recurrent cholangitis or obstructive jaundice

→ Think Clonorchis sinensis

Cancer Association

Chronic liver fluke infection

  • ●

Biliary tract inflammation

  • ●

Bile duct malignancy

→ Think cholangiocarcinoma associated with Clonorchis sinensis

Exam Essentials

Organism: Clonorchis sinensis

Common name: Chinese liver fluke

Type: Trematode helminth

Transmission: Eating raw or undercooked freshwater fish

Infective stage for humans: Metacercariae in fish

Adult location: Intrahepatic bile ducts

Major endemic areas: China, Korea, Taiwan, and parts of Southeast Asia

Disease: Clonorchiasis

Major manifestations: Biliary obstruction, jaundice, and recurrent cholangitis

Major long-term complication: Cholangiocarcinoma

Diagnosis: Eggs in concentrated stool or bile

Treatment of choice: Praziquantel

Alternative: Albendazole

Prevention: Thoroughly cook freshwater fish

Key clinical pearl: The classic association is raw freshwater fish → Clonorchis sinensis → chronic biliary inflammation → cholangiocarcinoma.


Image description
Published on

Infectious Disease and Microbiology – Citrobacter Species

Overview

Citrobacter species are aerobic Gram-negative bacilli that belong to the Enterobacterales and can cause a variety of opportunistic infections. They are increasingly important as healthcare-associated pathogens, particularly in hospitalized, debilitated, or immunocompromised patients.

The major clinically relevant species include Citrobacter freundii, Citrobacter koseri, and Citrobacter amalonaticus. Of particular importance, C. koseri has a strong association with neonatal meningitis and brain abscess formation.

Microbiologic Characteristics

Citrobacter organisms are Gram-negative bacilli and facultative anaerobes within the Enterobacterales.

Important characteristics include:

• Gram-negative rods

• Facultative anaerobic metabolism

• Growth on routine bacterial culture media

• Environmental and gastrointestinal reservoirs

They may colonize the human gastrointestinal tract without producing disease but can become pathogenic when host defenses are impaired or invasive devices are present.

Epidemiology

Citrobacter infections occur worldwide and have become increasingly recognized as causes of nosocomial infection.

Healthcare-associated disease is particularly associated with:

• Prolonged hospitalization

• Intensive care exposure

• Indwelling urinary catheters

• Central venous catheters

• Recent surgery

• Broad-spectrum antibiotic exposure

• Immunocompromised states

Because Citrobacter can colonize the gastrointestinal tract, infections may arise endogenously or through healthcare-associated transmission.

Clinical Infections

Urinary Tract Infection

Urinary tract infection is a common manifestation, particularly in hospitalized patients and those with urinary instrumentation.

Clinical presentations range from:

• Asymptomatic bacteriuria

• Cystitis

• Complicated UTI

• Pyelonephritis

• Urosepsis

Indwelling urinary catheters are an important predisposing factor.

Pulmonary Infection

Citrobacter can occasionally cause pneumonia, particularly in hospitalized or immunocompromised patients.

Manifestations may include:

• Fever

• Productive cough

• Dyspnea

• Hypoxemia

• Pulmonary infiltrates

Healthcare-associated and ventilator-associated infections are particularly relevant.

Catheter-Associated Bacteremia

Central venous and other intravascular catheters may become colonized and produce bloodstream infection.

Patients may develop:

• Fever and chills

• Persistent bacteremia

• Hypotension

• Sepsis or septic shock

Removal of an infected catheter may be necessary in addition to antimicrobial therapy.

Surgical Wound Infection

Citrobacter species can infect postoperative wounds and other disrupted skin or soft-tissue sites.

Clinical manifestations include:

• Erythema

• Swelling

• Pain

• Purulent drainage

• Wound dehiscence

• Fever

Deep infections may require drainage or surgical debridement in addition to antibiotics.

Neonatal Meningitis

One of the most important clinical associations is:

Citrobacter koseri → neonatal meningitis

C. koseri has a distinctive tendency to cause severe central nervous system infection in neonates and young infants.

Clinical manifestations may include:

• Fever or temperature instability

• Poor feeding

• Irritability

• Lethargy

• Seizures

• Bulging fontanelle

• Altered consciousness

Brain Abscess Formation

A particularly important feature of C. koseri neonatal meningitis is its tendency to produce:

Multiple brain abscesses

This propensity distinguishes C. koseri from many other causes of neonatal bacterial meningitis.

Complications can include:

• Cerebritis

• Multiple cerebral abscesses

• Ventriculitis

• Hydrocephalus

• Seizures

• Long-term neurologic impairment

Therefore, neuroimaging is often important when neonatal Citrobacter meningitis is suspected or confirmed.

Diagnosis

Diagnosis is established by culture of the organism from the affected site.

Depending on the clinical syndrome, specimens may include:

• Urine

• Blood

• Cerebrospinal fluid

• Respiratory specimens

• Wound material

• Abscess fluid

Identification should be followed by antimicrobial susceptibility testing, particularly because resistance patterns can vary substantially.

Antimicrobial Resistance

Resistance is an important consideration in Citrobacter infections.

In particular, C. freundii can possess inducible chromosomal AmpC beta-lactamase, which may confer resistance to several beta-lactam antibiotics.

This means that an isolate can sometimes appear initially susceptible to certain cephalosporins but subsequently develop clinically significant resistance during treatment.

Other resistance mechanisms, including extended-spectrum beta-lactamases and carbapenem resistance, may also occur.

Consequently, treatment of serious infection should be based on:

Species identification + susceptibility testing + infection severity and site

Treatment

Historically active antimicrobial classes include:

• Third-generation cephalosporins

• Antipseudomonal penicillins

• Carbapenems

• Fluoroquinolones

• Aztreonam

• Aminoglycosides

However, because resistance patterns have evolved considerably, these agents should not be assumed to be universally active.

Carbapenems

Agents such as:

• Meropenem

• Imipenem

may be appropriate for severe infections caused by susceptible organisms, particularly when significant beta-lactam resistance is present.

Fluoroquinolones

Fluoroquinolones may be effective against susceptible isolates and can be useful for selected infections, particularly when adequate tissue penetration and an oral treatment option are needed.

Aminoglycosides

An aminoglycoside may have activity against susceptible isolates.

Historically, aminoglycosides have sometimes been added to another active agent in severe Citrobacter infection, although combination therapy is not automatically required for every patient.

Source Control

Antibiotics alone may be insufficient when an infected foreign body or localized collection is present.

Management may therefore include:

• Removal of an infected vascular catheter

• Removal or replacement of an infected urinary catheter

• Drainage of abscesses

• Debridement of infected surgical wounds

High-Yield Clinical Pattern

Neonate

  • ●

Gram-negative meningitis

  • ●

Multiple cerebral abscesses

→ Strongly consider Citrobacter koseri

Hospital-Acquired Pattern

Hospitalized patient

  • ●

Urinary or central venous catheter

  • ●

Gram-negative UTI or bacteremia

→ Citrobacter species should be included among possible healthcare-associated Enterobacterales.

Exam Essentials

Genus: Citrobacter

Important species: C. freundii, C. koseri, C. amalonaticus

Microbiology: Gram-negative bacilli, Enterobacterales

Epidemiology: Increasingly important healthcare-associated pathogens

Major infections: UTI, pneumonia, catheter-associated bacteremia, surgical wound infection

Classic neonatal pathogen: C. koseri

Classic complication: Neonatal meningitis with multiple brain abscesses

Diagnosis: Culture with antimicrobial susceptibility testing

Important resistance mechanism: C. freundii may express AmpC beta-lactamase

Potential treatments: Selected according to susceptibility; options may include carbapenems, fluoroquinolones, and other active Gram-negative agents

Source control: Remove infected devices and drain collections when indicated

Key clinical pearl: The association most worth remembering is Citrobacter koseri → neonatal meningitis → multiple brain abscesses, while C. freundii is particularly important for its potential AmpC-mediated antimicrobial resistance.


Image description
Published on

Infectious Disease and Microbiology – Chrysosporium parvum

Overview

Chrysosporium parvum is a rare filamentous fungal pathogen capable of producing localized or invasive infections in humans. Although disease is uncommon, infections may involve the lungs, bones, paranasal sinuses, heart valves, and, particularly in immunocompromised patients, multiple organ systems.

Microbiologic Characteristics

Chrysosporium parvum is a filamentous fungus (mold).

In infected tissue, it characteristically appears as:

• Hyaline fungal elements

• Septate hyphae

The term hyaline refers to the relatively nonpigmented appearance of the fungal hyphae, distinguishing it from dematiaceous fungi that contain dark pigment.

Epidemiology

The organism has a worldwide distribution, but documented human infections are rare.

Invasive disease is of greatest concern in patients with impaired host defenses, particularly those with substantial immunosuppression.

Clinical Infections

Osteomyelitis

Chrysosporium parvum can rarely infect bone and cause fungal osteomyelitis.

Patients may develop:

• Localized bone pain

• Swelling

• Reduced function

• Chronic inflammatory changes

Diagnosis generally requires culture and examination of infected tissue.

Pulmonary Infection

Pulmonary disease may occur following respiratory acquisition of fungal elements.

Manifestations can include:

• Fever

• Cough

• Dyspnea

• Chest discomfort

• Pulmonary infiltrates

The diagnosis may be particularly challenging in immunocompromised patients because the presentation can resemble other invasive mold infections.

Prosthetic Valve Endocarditis

Rarely, C. parvum may cause prosthetic valve endocarditis.

Possible manifestations include:

• Persistent fever

• Cardiac murmur

• Embolic complications

• Prosthetic valve dysfunction

• Evidence of systemic fungal infection

Fungal prosthetic valve endocarditis represents a serious invasive infection requiring specialist management.

Rhinitis and Sinusitis

The organism may cause rhinitis or fungal sinusitis.

Disease can involve the nasal cavity and paranasal sinuses and may occasionally become locally invasive.

Possible symptoms include:

• Nasal congestion

• Facial pain or pressure

• Nasal discharge

• Headache

Central Nervous System Extension

Sinus infection may rarely extend directly into adjacent structures and involve the central nervous system.

CNS involvement represents a severe complication and may manifest with neurologic abnormalities, altered mental status, headache, seizures, or focal deficits depending on the site of infection.

Disseminated Infection

Immunocompromised patients are at risk for disseminated disease, in which infection spreads beyond its initial site to involve multiple organs.

This manifestation should be considered when a susceptible patient has evidence of invasive mold infection at more than one anatomic site.

Diagnosis

Fungal Culture

The principal diagnostic method is:

Culture of the fungus from an appropriate clinical specimen

Specimens may include:

• Respiratory material

• Sinus specimens

• Bone specimens

• Blood or cardiovascular tissue when appropriate

• Material obtained from other infected sites

Identification of the organism is important because several hyaline molds can have similar appearances in tissue.

Tissue Biopsy

Identification of fungal elements within a tissue biopsy provides important evidence of invasive disease.

Histopathologic examination may demonstrate septate hyaline hyphae invading affected tissue.

Whenever possible, tissue should be submitted for both:

Histopathology + fungal culture

This helps establish tissue invasion while allowing identification of the responsible organism.

Treatment

Amphotericin B

The traditional treatment described for invasive Chrysosporium parvum infection is:

Intravenous amphotericin B

Treatment duration depends on factors such as:

• Site of infection

• Severity of disease

• Degree of immunosuppression

• Clinical and radiologic response

• Ability to achieve surgical source control

Because these infections are rare, treatment should generally be individualized with infectious disease and clinical microbiology input.

Surgical Management

Although not required for every infection, surgical intervention may be important for localized invasive disease, particularly when there is:

• Infected or necrotic bone

• Extensive sinus disease

• CNS extension

• Prosthetic material involvement

• A localized focus that cannot be eradicated medically

Prosthetic valve endocarditis may require combined antifungal and surgical management.

High-Yield Clinical Pattern

Immunocompromised patient

  • ●

Pulmonary, sinus, bone, or disseminated fungal infection

  • ●

Septate hyaline hyphae in tissue

  • ●

Culture identifying Chrysosporium

→ Consider invasive Chrysosporium parvum infection.

Differential Microbiology

When septate hyaline hyphae are identified in tissue, the differential diagnosis includes several other molds, particularly:

• Aspergillus

• Fusarium

• Scedosporium

• Other hyaline molds

Therefore, morphology alone may not reliably establish the species, and culture or molecular identification can be important.

Exam Essentials

Organism: Chrysosporium parvum

Type: Filamentous fungus (mold)

Tissue morphology: Septate hyaline hyphae

Distribution: Worldwide but rare

Major infections: Osteomyelitis, pulmonary infection, sinusitis, and prosthetic valve endocarditis

Severe complication: CNS extension from rhinosinusitis

High-risk population: Immunocompromised patients

Dissemination: Particularly associated with impaired immunity

Diagnosis: Fungal culture and identification in tissue biopsy

Traditional treatment: Intravenous amphotericin B

Key clinical pearl: Chrysosporium parvum should be considered among the uncommon hyaline molds when an immunocompromised patient develops invasive pulmonary, sinus, osseous, or disseminated fungal disease.


Image description
Published on

Infectious Disease and Microbiology – Chromoblastomycosis Agents

Overview

Chromoblastomycosis, also called chromomycosis or dermatitis verrucosa, is a chronic fungal infection of the skin and subcutaneous tissues caused by several dematiaceous (darkly pigmented) fungi. Infection typically follows traumatic implantation of the fungus into the skin and develops slowly over months to years.

The disease classically produces chronic verrucous or wart-like lesions of the lower extremities, particularly in barefoot agricultural workers living in tropical and subtropical regions.

Causative Species

Several fungi can cause chromoblastomycosis, including:

• Cladophialophora carrionii (formerly Cladosporium carrionii)

• Fonsecaea compacta

• Fonsecaea pedrosoi — the most common cause

• Phialophora verrucosa

• Rhinocladiella aquaspersa

These organisms are environmental fungi associated particularly with soil, vegetation, and decaying plant material.

Microbiologic Characteristics

The causative organisms are dematiaceous filamentous fungi, meaning that their cell walls contain melanin and therefore appear brown or darkly pigmented.

They characteristically form:

• Septate hyphae in culture

• Pigmented fungal elements in infected tissue

• Sclerotic bodies within tissue

The presence of sclerotic bodies is one of the most important diagnostic features of chromoblastomycosis.

Sclerotic Bodies

In tissue, the fungi transform into characteristic thick-walled, brown, rounded structures known as:

Sclerotic bodies

They are also called:

• Medlar bodies

• Muriform bodies

• Copper-penny bodies

They may divide along multiple planes, producing a characteristic appearance resembling copper pennies.

Sclerotic bodies in a chronic verrucous skin lesion are highly characteristic of chromoblastomycosis.

Incubation Period

The exact incubation period is uncertain because the infection progresses very slowly.

It is probably at least several months, and clinically apparent disease may develop long after the initial traumatic inoculation.

Epidemiology

Chromoblastomycosis occurs worldwide but is most prevalent in tropical and subtropical regions, particularly in developing countries.

It is associated strongly with:

• Rural residence

• Agricultural work

• Walking barefoot

• Frequent contact with soil and vegetation

• Minor penetrating injuries from thorns, wood, or plant material

The lower extremities are affected most often because they are particularly vulnerable to traumatic inoculation.

Pathogenesis

Infection usually begins when contaminated plant material or soil causes a small penetrating injury.

The fungus is introduced directly into:

Skin → subcutaneous tissue

The organism then produces a slowly progressive local inflammatory response.

Unlike many invasive fungal infections, chromoblastomycosis commonly occurs in otherwise immunocompetent individuals because infection results primarily from direct traumatic implantation rather than systemic acquisition.

Clinical Manifestations

Chromoblastomycosis is typically a chronic, slowly progressive cutaneous and subcutaneous infection.

The initial lesion may begin as a small papule or nodule at the site of traumatic inoculation.

Over time, it can enlarge and develop into:

• Verrucous plaques

• Warty nodules

• Papillomatous lesions

• Tumor-like masses

• Crusted plaques

Lesions may resemble large warts or cauliflower-like growths.

Typical Location

The most characteristic location is the:

Lower extremity

Feet and legs are especially commonly affected because of exposure to contaminated soil and vegetation.

Other body regions may occasionally become involved following traumatic implantation.

Chronic Disease

Progression is generally slow, often occurring over years.

As lesions enlarge, patients may develop:

• Secondary bacterial infection

• Ulceration

• Fibrosis

• Lymphatic obstruction

• Lymphedema

• Functional impairment

Extensive disease can become difficult to eradicate.

Dissemination

Chromoblastomycosis generally remains localized to the skin and subcutaneous tissues.

Rarely, deeper extension or dissemination can involve:

• Muscle

• Central nervous system

• Lungs

Such invasive disease is unusual.

Diagnosis

Diagnosis depends on demonstrating the characteristic fungal structures in affected tissue and identifying the causative organism by culture.

Histopathology

The classic diagnostic finding is:

Sclerotic bodies

These are brown, thick-walled fungal structures present within infected tissue.

Their appearance is sufficiently characteristic that identifying them in the appropriate clinical setting strongly supports chromoblastomycosis.

Culture

Fungal culture is used to determine the specific causative organism.

Identification depends on:

• Colony morphology

• Pigmentation

• Microscopic morphology

• Characteristic sporulation patterns

Culture is particularly useful because several different dematiaceous fungi can produce the same clinical syndrome.

Differential Diagnosis

Chronic verrucous lesions can resemble several infectious and noninfectious conditions, including:

• Sporotrichosis

• Mycetoma

• Cutaneous tuberculosis

• Leprosy

• Cutaneous leishmaniasis

• Phaeohyphomycosis

• Verrucous bacterial infections

• Squamous cell carcinoma

Finding sclerotic bodies helps distinguish chromoblastomycosis from other implantation mycoses.

Treatment

Treatment can be difficult, particularly when lesions are large or longstanding. There is no single universally effective regimen.

Management depends largely on lesion size, location, and extent.

Small Lesions

Small, localized lesions may be treated with:

Surgical excision

or

Cryotherapy

Complete removal is most successful when disease is detected early and remains well localized.

Itraconazole

Itraconazole is an important systemic treatment option.

Treatment usually needs to be prolonged:

At least 6 months, and often considerably longer depending on clinical response.

Itraconazole may be combined with:

• Cryotherapy

• Surgical excision

• Other local destructive techniques

Combination therapy can be particularly useful for larger or more persistent lesions.

Terbinafine

Terbinafine is another important systemic antifungal option and may be used alone or as part of combination management.

Extensive or Refractory Disease

For extensive disease, historical treatment approaches have included:

Flucytosine + amphotericin B

More recently, broad-spectrum triazole antifungals may have activity against some causative organisms.

Treatment should ideally be guided by the specific organism, disease severity, and clinical response.

Prevention

Because infection usually follows traumatic implantation, prevention focuses on protecting the skin from contaminated soil and vegetation.

Protective measures include:

• Wearing shoes or boots

• Wearing long trousers and protective clothing

• Wearing gloves during agricultural work

• Promptly cleaning penetrating skin injuries

These precautions reduce exposure to thorns, splinters, and other materials capable of introducing the fungus into subcutaneous tissues.

High-Yield Clinical Pattern

Barefoot agricultural worker in a tropical region

  • ●

History of traumatic inoculation

  • ●

Slowly progressive verrucous or cauliflower-like lesion on the leg

  • ●

Brown sclerotic bodies on histology

→ Think chromoblastomycosis

Key Diagnostic Distinction

Chromoblastomycosis

→ Sclerotic (Medlar/copper-penny) bodies

Phaeohyphomycosis

→ Pigmented hyphae or yeast-like fungal elements in tissue, without characteristic sclerotic bodies

Mycetoma

→ Tumefaction + draining sinus tracts + grains

This distinction is particularly useful in microbiology and infectious disease examinations.

Exam Essentials

Disease: Chromoblastomycosis

Other names: Chromomycosis, dermatitis verrucosa

Organisms: Dematiaceous fungi

Most common species: Fonsecaea pedrosoi

Transmission: Traumatic implantation from soil or vegetation

Typical patient: Rural agricultural worker in a tropical/subtropical region

Typical site: Lower extremities

Typical lesion: Chronic verrucous/warty plaque or nodule

Characteristic tissue finding: Sclerotic bodies

Other names for sclerotic bodies: Medlar bodies, muriform bodies, copper-penny bodies

Diagnosis: Histopathology + fungal culture

Localized treatment: Excision or cryotherapy

Systemic treatment: Prolonged itraconazole or terbinafine

Prevention: Protective shoes and clothing

Key clinical pearl: The combination of a chronic verrucous lower-extremity lesion after traumatic soil or plant exposure and brown copper-penny–like sclerotic bodies in tissue is the classic presentation of chromoblastomycosis.


Image description
Published on

Infectious Disease and Microbiology – Chromobacterium violaceum


Overview


Chromobacterium violaceum is a rare environmental Gram-negative bacillus that can cause serious human infection after traumatic inoculation or exposure to contaminated water. Although infection is uncommon, it can progress rapidly from a localized wound infection to bacteremia, sepsis, pneumonia, or metastatic abscesses.


Severe disease is especially concerning in patients with chronic granulomatous disease or significant neutrophil dysfunction.


Microbiologic Characteristics


Chromobacterium violaceum is an aerobic Gram-negative bacillus.


Many strains produce a characteristic violet pigment known as violacein, which may give colonies a purple appearance in culture. However, not all strains are pigmented, so absence of violet coloration does not exclude the organism.


Epidemiology


The organism is distributed worldwide, particularly in tropical and subtropical environments.


It is found mainly in:


• Soil


• Fresh water


• Mud


• Natural water sources


Human infection is rare and usually follows environmental exposure.


Transmission


Infection most often occurs when contaminated soil or water enters through a break in the skin.


Typical routes include:


• Traumatic wounds


• Puncture injuries


• Cuts exposed to contaminated water


• Near-drowning or aspiration of contaminated water


The organism can invade locally and then spread hematogenously.


Risk Factors


Important risk factors for severe disease include:


• Chronic granulomatous disease


• Neutropenia


• Other disorders of phagocyte function


• Significant immunosuppression


Patients with chronic granulomatous disease are particularly susceptible because of impaired intracellular killing of certain catalase-positive organisms.


Clinical Infections


Traumatic Wound Infection


Localized infection may develop after environmental contamination of a wound.


Possible findings include:


• Pain


• Erythema


• Swelling


• Purulent drainage


• Cellulitis


• Abscess formation


Because progression can be rapid, patients with systemic symptoms should be assessed for bloodstream spread.


Sepsis


One of the most serious manifestations is bacteremia with sepsis.


Clinical findings may include:


• High fever


• Hypotension


• Tachycardia


• Altered mental status


• Septic shock


• Multiorgan dysfunction


Severe systemic infection is especially important in neutropenic patients and those with chronic granulomatous disease.


Metastatic Abscesses


Hematogenous dissemination may lead to abscess formation in distant organs.


Potential sites include:


• Liver


• Lung


• Spleen


• Brain


• Skin and soft tissues


Persistent fever despite therapy should raise concern for metastatic infection.


Pneumonia


Pneumonia can occur after aspiration of contaminated water, particularly following drowning or near-drowning.


Patients may develop:


• Fever


• Cough


• Dyspnea


• Hypoxemia


• Pulmonary infiltrates


A history of freshwater exposure can provide an important diagnostic clue.


Diagnosis


Diagnosis is established primarily by culture.


Appropriate specimens may include:


• Wound material


• Blood


• Respiratory secretions


• Abscess fluid


• Tissue specimens


The characteristic violet pigmentation, when present, can strongly suggest C. violaceum, but definitive identification requires microbiologic testing.


Treatment


Doxycycline


Doxycycline has activity against C. violaceum and may be useful in susceptible infections.


Fluoroquinolones


Fluoroquinolones, particularly agents such as ciprofloxacin, have historically shown good activity and may be used when susceptibility supports treatment.


Severe Infection


For serious systemic disease, treatment may include a broad-spectrum active agent such as:


• Imipenem


or historically


• A ureidopenicillin in combination with an aminoglycoside


Because antimicrobial susceptibility can vary, severe infection should be treated according to culture and susceptibility results.


Additional Treatment Options


Other agents that may have activity include:


• Trimethoprim-sulfamethoxazole


• Aminoglycosides


Therapy should be individualized based on the infection site, disease severity, and microbiology results.


Source Control


Abscesses and infected wounds may require:


• Surgical drainage


• Debridement


• Removal of devitalized tissue


Source control is especially important in patients with deep or metastatic infection.


Prevention


Prevention includes careful wound protection and avoidance of contamination with untreated freshwater or soil, particularly in high-risk patients.


Important measures include:


• Clean traumatic wounds promptly


• Cover open wounds during freshwater exposure


• Avoid swimming with significant open wounds


• Use particular caution in patients with chronic granulomatous disease


High-Yield Clinical Pattern


Freshwater or soil-contaminated wound


Rapidly progressive infection


Sepsis or metastatic abscesses


→ Think Chromobacterium violaceum


High-Yield Risk Pattern


Patient with chronic granulomatous disease


Severe Gram-negative sepsis after environmental exposure


→ Consider C. violaceum


Exam Essentials


Organism: Chromobacterium violaceum


Microbiology: Aerobic Gram-negative bacillus


Environmental reservoir: Soil and freshwater


Characteristic culture clue: Violet pigment in many strains


Major infections: Wound infection, bacteremia/sepsis, pneumonia


Important complication: Metastatic abscess formation


Major risk factor: Chronic granulomatous disease


Diagnosis: Culture


Commonly active agents: Doxycycline or fluoroquinolones


Severe infection: Carbapenem-based therapy may be appropriate


Additional agents: TMP-SMX or aminoglycosides


Key clinical pearl: A rapidly progressive infection after freshwater or soil exposure, especially in a patient with chronic granulomatous disease, should raise concern for Chromobacterium violaceum.

Image description
Published on

Infectious Disease and Microbiology – Chlamydophila Species

Overview

Chlamydophila species are obligate intracellular Gram-negative bacteria that primarily cause respiratory infections. The two clinically important organisms are Chlamydophila pneumoniae and Chlamydophila psittaci.

C. pneumoniae is an established cause of community-acquired atypical pneumonia, while C. psittaci causes psittacosis, a zoonotic infection typically acquired from birds.


Important Species

Chlamydophila pneumoniae

C. pneumoniae, historically referred to as TWAR, is transmitted from person to person and causes a proportion of community-acquired respiratory infections.

Chlamydophila psittaci

C. psittaci is associated mainly with birds and causes psittacosis in humans.

Exposure is particularly important among:

• Bird owners

• Poultry workers

• Veterinarians

• Pet-shop employees

• Animal handlers


Microbiologic Characteristics

Chlamydophila species are:

• Gram-negative bacteria

• Obligate intracellular organisms

• Unable to replicate independently outside host cells

Like other chlamydial organisms, they undergo a specialized intracellular developmental cycle.


Epidemiology

C. pneumoniae has a worldwide distribution and spreads primarily through respiratory secretions from person to person.

C. psittaci is maintained in birds and some domestic animals. Humans usually acquire infection by inhaling aerosolized material contaminated with infected bird secretions, respiratory droplets, or dried feces.


Chlamydophila pneumoniae Infection

Respiratory Disease

C. pneumoniae is an important cause of atypical respiratory infection.

Clinical syndromes include:

• Pharyngitis

• Sinusitis

• Bronchitis

• Community-acquired pneumonia

The illness is often gradual in onset.

Patients may develop:

• Low-grade fever

• Headache

• Malaise

• Sore throat

• Hoarseness

• Persistent dry cough

The cough may persist for several weeks even after other symptoms improve.


Pneumonia

Pneumonia caused by C. pneumoniae is usually relatively mild but may occasionally be more significant in older adults or patients with chronic underlying disease.

The presentation may resemble infections caused by:

• Mycoplasma pneumoniae

• Respiratory viruses

• Legionella species


Chlamydophila psittaci Infection

Psittacosis

C. psittaci causes psittacosis, also called ornithosis.

The classic epidemiologic clue is:

Bird exposure + atypical pneumonia

Symptoms may include:

• High fever

• Severe headache

• Myalgias

• Malaise

• Dry cough

• Dyspnea

• Pneumonia

Some patients develop systemic manifestations involving the liver, nervous system, or other organs.


Associated Animals

Birds are the most important reservoirs, particularly:

• Parrots

• Parakeets

• Cockatiels

• Pigeons

• Poultry

Infected birds may appear healthy while shedding the organism.


Possible Association With Atherosclerosis

C. pneumoniae has been investigated as a possible contributor to the development of atherosclerosis.

Although organisms and immune responses have been detected in atherosclerotic tissue, a direct causal role has not been established sufficiently to justify antimicrobial therapy for prevention or treatment of atherosclerosis.


Diagnosis

Diagnosis may be made using:

• PCR

• Serology

• Antigen detection

• Cell culture

Because these organisms are intracellular and difficult to cultivate, molecular and serologic methods are generally more practical than routine culture.


PCR

PCR can detect organism-specific nucleic acid in respiratory specimens.

This provides direct evidence of infection and is especially useful when available.


Serology

Traditional methods include:

• Complement fixation

• Microimmunofluorescence

Microimmunofluorescence has historically been used to distinguish antibody responses to different chlamydial species.

For psittacosis, older diagnostic criteria considered a complement-fixing antibody titer greater than 1:16 supportive in an appropriate clinical setting, although modern diagnostic interpretation generally relies on paired serology or molecular testing.


Antigen Detection

Antigen-detection assays may also identify chlamydial antigens in clinical specimens, although PCR has largely become more useful where available.


Cell Culture

Culture is possible but difficult because the organism requires living cells for replication.

It is mainly performed in specialized or reference laboratories.


Differential Diagnosis

For C. pneumoniae respiratory infection, consider:

• Mycoplasma pneumoniae

• Legionella

• Influenza

• Other respiratory viruses

• Typical bacterial pneumonia

For psittacosis, consider:

• Q fever

• Legionnaires’ disease

• Influenza

• Tularemia

• Other causes of atypical pneumonia

A strong bird-exposure history is particularly helpful for distinguishing psittacosis.


Treatment

Doxycycline

For pneumonia caused by C. pneumoniae, the source regimen is:

Doxycycline 100 mg orally every 12 hours for 10–14 days

Doxycycline is also a major treatment option for psittacosis.


Macrolides

Additional effective agents include:

• Azithromycin

• Clarithromycin

These may be especially useful when tetracyclines are unsuitable.


Tetracycline

Tetracycline-class antibiotics are active against these intracellular organisms and have historically been used extensively for both C. pneumoniae and C. psittaci infections.


Fluoroquinolones

Respiratory fluoroquinolones such as:

• Levofloxacin

may also have activity and can be considered in selected patients.


Prevention

For C. pneumoniae, prevention relies on general respiratory hygiene because infection spreads person to person.

For C. psittaci, prevention includes:

• Proper handling of birds

• Avoiding inhalation of dried bird droppings

• Cleaning cages carefully

• Using protective equipment during high-risk occupational exposure

• Veterinary evaluation of infected birds


High-Yield Clinical Patterns

Chlamydophila pneumoniae

Gradual respiratory illness

  • ●

Persistent dry cough

  • ●

Community-acquired atypical pneumonia

→ Think C. pneumoniae

Chlamydophila psittaci

Bird exposure

  • ●

High fever

  • ●

Severe headache

  • ●

Atypical pneumonia

→ Think psittacosis


Exam Essentials

Genus: Chlamydophila

Important species:

→ C. pneumoniae

→ C. psittaci

Microbiology:

→ Gram-negative obligate intracellular bacteria

C. pneumoniae transmission:

→ Person to person

C. pneumoniae disease:

→ Community-acquired atypical pneumonia

C. psittaci reservoir:

→ Birds

C. psittaci disease:

→ Psittacosis

Classic psittacosis clue:

→ Bird exposure + atypical pneumonia

Diagnosis:

→ PCR, serology, antigen detection, specialized culture

Treatment:

→ Doxycycline

Other options:

→ Azithromycin, clarithromycin, tetracycline, levofloxacin

Key distinction:

C. pneumoniae → person-to-person respiratory infection

C. psittaci → zoonotic bird-associated pneumonia


Image description
Published on

Infectious Disease and Microbiology – Chlamydophila Species

Overview

Chlamydophila species are obligate intracellular Gram-negative bacteria that primarily cause respiratory infections. The two clinically important organisms are Chlamydophila pneumoniae and Chlamydophila psittaci.

C. pneumoniae is an established cause of community-acquired atypical pneumonia, while C. psittaci causes psittacosis, a zoonotic infection typically acquired from birds.


Important Species

Chlamydophila pneumoniae

C. pneumoniae, historically referred to as TWAR, is transmitted from person to person and causes a proportion of community-acquired respiratory infections.

Chlamydophila psittaci

C. psittaci is associated mainly with birds and causes psittacosis in humans.

Exposure is particularly important among:

• Bird owners

• Poultry workers

• Veterinarians

• Pet-shop employees

• Animal handlers


Microbiologic Characteristics

Chlamydophila species are:

• Gram-negative bacteria

• Obligate intracellular organisms

• Unable to replicate independently outside host cells

Like other chlamydial organisms, they undergo a specialized intracellular developmental cycle.


Epidemiology

C. pneumoniae has a worldwide distribution and spreads primarily through respiratory secretions from person to person.

C. psittaci is maintained in birds and some domestic animals. Humans usually acquire infection by inhaling aerosolized material contaminated with infected bird secretions, respiratory droplets, or dried feces.


Chlamydophila pneumoniae Infection

Respiratory Disease

C. pneumoniae is an important cause of atypical respiratory infection.

Clinical syndromes include:

• Pharyngitis

• Sinusitis

• Bronchitis

• Community-acquired pneumonia

The illness is often gradual in onset.

Patients may develop:

• Low-grade fever

• Headache

• Malaise

• Sore throat

• Hoarseness

• Persistent dry cough

The cough may persist for several weeks even after other symptoms improve.


Pneumonia

Pneumonia caused by C. pneumoniae is usually relatively mild but may occasionally be more significant in older adults or patients with chronic underlying disease.

The presentation may resemble infections caused by:

• Mycoplasma pneumoniae

• Respiratory viruses

• Legionella species


Chlamydophila psittaci Infection

Psittacosis

C. psittaci causes psittacosis, also called ornithosis.

The classic epidemiologic clue is:

Bird exposure + atypical pneumonia

Symptoms may include:

• High fever

• Severe headache

• Myalgias

• Malaise

• Dry cough

• Dyspnea

• Pneumonia

Some patients develop systemic manifestations involving the liver, nervous system, or other organs.


Associated Animals

Birds are the most important reservoirs, particularly:

• Parrots

• Parakeets

• Cockatiels

• Pigeons

• Poultry

Infected birds may appear healthy while shedding the organism.


Possible Association With Atherosclerosis

C. pneumoniae has been investigated as a possible contributor to the development of atherosclerosis.

Although organisms and immune responses have been detected in atherosclerotic tissue, a direct causal role has not been established sufficiently to justify antimicrobial therapy for prevention or treatment of atherosclerosis.


Diagnosis

Diagnosis may be made using:

• PCR

• Serology

• Antigen detection

• Cell culture

Because these organisms are intracellular and difficult to cultivate, molecular and serologic methods are generally more practical than routine culture.


PCR

PCR can detect organism-specific nucleic acid in respiratory specimens.

This provides direct evidence of infection and is especially useful when available.


Serology

Traditional methods include:

• Complement fixation

• Microimmunofluorescence

Microimmunofluorescence has historically been used to distinguish antibody responses to different chlamydial species.

For psittacosis, older diagnostic criteria considered a complement-fixing antibody titer greater than 1:16 supportive in an appropriate clinical setting, although modern diagnostic interpretation generally relies on paired serology or molecular testing.


Antigen Detection

Antigen-detection assays may also identify chlamydial antigens in clinical specimens, although PCR has largely become more useful where available.


Cell Culture

Culture is possible but difficult because the organism requires living cells for replication.

It is mainly performed in specialized or reference laboratories.


Differential Diagnosis

For C. pneumoniae respiratory infection, consider:

• Mycoplasma pneumoniae

• Legionella

• Influenza

• Other respiratory viruses

• Typical bacterial pneumonia

For psittacosis, consider:

• Q fever

• Legionnaires’ disease

• Influenza

• Tularemia

• Other causes of atypical pneumonia

A strong bird-exposure history is particularly helpful for distinguishing psittacosis.


Treatment

Doxycycline

For pneumonia caused by C. pneumoniae, the source regimen is:

Doxycycline 100 mg orally every 12 hours for 10–14 days

Doxycycline is also a major treatment option for psittacosis.


Macrolides

Additional effective agents include:

• Azithromycin

• Clarithromycin

These may be especially useful when tetracyclines are unsuitable.


Tetracycline

Tetracycline-class antibiotics are active against these intracellular organisms and have historically been used extensively for both C. pneumoniae and C. psittaci infections.


Fluoroquinolones

Respiratory fluoroquinolones such as:

• Levofloxacin

may also have activity and can be considered in selected patients.


Prevention

For C. pneumoniae, prevention relies on general respiratory hygiene because infection spreads person to person.

For C. psittaci, prevention includes:

• Proper handling of birds

• Avoiding inhalation of dried bird droppings

• Cleaning cages carefully

• Using protective equipment during high-risk occupational exposure

• Veterinary evaluation of infected birds


High-Yield Clinical Patterns

Chlamydophila pneumoniae

Gradual respiratory illness

  • ●

Persistent dry cough

  • ●

Community-acquired atypical pneumonia

→ Think C. pneumoniae

Chlamydophila psittaci

Bird exposure

  • ●

High fever

  • ●

Severe headache

  • ●

Atypical pneumonia

→ Think psittacosis


Exam Essentials

Genus: Chlamydophila

Important species:

→ C. pneumoniae

→ C. psittaci

Microbiology:

→ Gram-negative obligate intracellular bacteria

C. pneumoniae transmission:

→ Person to person

C. pneumoniae disease:

→ Community-acquired atypical pneumonia

C. psittaci reservoir:

→ Birds

C. psittaci disease:

→ Psittacosis

Classic psittacosis clue:

→ Bird exposure + atypical pneumonia

Diagnosis:

→ PCR, serology, antigen detection, specialized culture

Treatment:

→ Doxycycline

Other options:

→ Azithromycin, clarithromycin, tetracycline, levofloxacin

Key distinction:

C. pneumoniae → person-to-person respiratory infection

C. psittaci → zoonotic bird-associated pneumonia


Image description